Stratec SE (LTS:0RAR) Change In Receivables: €0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RAR Stratec SE LTS:0RAR
71 GF Score
Price €22.90
GF Value €27.96
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Stratec SE Change In Receivables?

Stratec SE LTS:0RAR -0.65% 71 Change In Receivables is €0.0 Mil as of Jun. 2026. GuruFocus rates LTS:0RAR with a GF Score™ of 71/100 and a GF Value™ of €27.96 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Stratec SE's change in receivables for the quarter that ended in Jun. 2026 was €0.0 Mil. It means Stratec SE's Accounts Receivable stayed the same from Mar. 2026 to Jun. 2026 .

Stratec SE's change in receivables for the fiscal year that ended in Dec. 2025 was €0.0 Mil. It means Stratec SE's Accounts Receivable stayed the same from Dec. 2024 to Dec. 2025 .

Stratec SE's Accounts Receivable for the quarter that ended in Jun. 2026 was €45.9 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Stratec SE's Days Sales Outstanding for the three months ended in Jun. 2026 was 70.87.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Stratec SE's liquidation value for the three months ended in Jun. 2026 was €-61.4 Mil.

Stratec SE  (LTS:0RAR) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Stratec SE's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=45.905/59.11*91
=70.87

2. In Ben Graham's calculation of liquidation value, Stratec SE's accounts receivable are only considered to be worth 75% of book value:

Stratec SE's liquidation value for the quarter that ended in Jun. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=20.605-172.294+0.75 * 45.905+0.5 * 111.779
=-61.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stratec SE Change In Receivables Related Terms

Stratec SE Change In Receivables Historical Data

* Premium members only.

The historical data trend for Stratec SE's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stratec SE Change In Receivables Chart

Stratec SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Stratec SE Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LTS:0RAR
71GF Score
Stratec SE LTS:0RAR
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stratec SE Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of €0.0 Mil mean?
Stratec SE (LTS:0RAR) has a Change In Receivables of €0.0 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Stratec SE and its competitors.
Is Stratec SE's Change In Receivables too high?
Stratec SE's current Change In Receivables is €0.0 Mil. Overall, Stratec SE has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stratec SE's Change In Receivables compare to ABT and SYK?
Stratec SE's Change In Receivables of €0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Stratec SE and its competitors. Stratec SE's current Change In Receivables is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stratec SE stock overvalued right now?
Based on GuruFocus' analysis, Stratec SE (LTS:0RAR) is currently considered Modestly Undervalued. The stock's GF Value™ is €27.96, compared to a current price of €22.90 — trading 18.1% below its estimated fair value. The current Change In Receivables is €0.0 Mil. Stratec SE's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Stratec SE (LTS:0RAR), the current Change In Receivables is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stratec SE (LTS:0RAR) Overvalued in 2026?

Based on GuruFocus' analysis, Stratec SE stock appears to be undervalued. The current stock price of €22.90 is trading 18.1% below its estimated GF Value™ of €27.96. GuruFocus considers Stratec SE to be Modestly Undervalued.

Key valuation signals for LTS:0RAR:

  • Change In Receivables: €0.0 Mil
  • GF Value™: €27.96 vs. price of €22.90 (18.1% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the LTS:0RAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stratec SE Business Description

Other Exchanges SBS:GermanySBSG:Austria
Address Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Stratec SE designs and manufactures automation solutions for regulated laboratory markets. STRATEC acts as an OEM partner to players in the in-vitro diagnostics and life sciences markets. The Group's product range includes both hardware solutions, software solutions, and related consumables, as well as independently marketed consumables. These products are mostly combined into fully integrated system solutions and often receive market approval together with partners' reagents.
71GF Score

Get the complete analysis for LTS:0RAR

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.90
Price
€27.96
GF Value